The most effective way to prevent bacterial meningitis is vaccination, combined with basic hygiene habits that limit the spread of the bacteria responsible for the disease. Several vaccines now target the three most common bacterial causes, and when given on schedule, they provide strong protection. Beyond vaccines, avoiding shared personal items, getting preventive antibiotics after a known exposure, and understanding your personal risk factors all play a role.
Vaccines That Protect Against Meningitis
Three types of bacteria cause most cases of bacterial meningitis: meningococcus, pneumococcus, and Haemophilus influenzae type b (Hib). Each has its own vaccine, and the schedules differ by age.
Meningococcal Vaccines
The MenACWY vaccine covers four of the most dangerous strains of meningococcal bacteria. The standard schedule calls for a first dose at age 11 or 12, with a booster at 16. That booster is important because protection fades over time, and the years between 16 and 21 carry the highest risk for teens and young adults.
A separate vaccine, MenB, targets a fifth strain. This one isn’t on the routine schedule for every teenager. Instead, it’s recommended through shared decision-making between you and your doctor, typically for those aged 16 to 23. It’s strongly recommended for people at higher risk, including anyone with certain immune deficiencies or a missing or nonfunctional spleen. In clinical studies, the MenB vaccine was up to 95% effective in fully immunized young children, with even partial immunization providing substantial protection.
A newer pentavalent vaccine combines MenACWY and MenB into a single shot. It can be used when both vaccines are indicated at the same visit, for healthy people aged 16 to 23 or for high-risk individuals aged 10 and older. The two-dose series is spaced six months apart. One important detail: serogroup B vaccines from different manufacturers are not interchangeable, so you need to complete your series with the same brand you started with.
Pneumococcal and Hib Vaccines
For infants, the pneumococcal conjugate vaccine (PCV20) is given at 2, 4, 6, and 12 to 15 months. Pneumococcal bacteria are a leading cause of bacterial meningitis in very young children, and this vaccine has dramatically reduced those cases. The Hib vaccine follows a similar infant schedule and is often given at the same visits. Together, these two vaccines cover the bacteria most likely to cause meningitis in children under five.
Who Faces the Highest Risk
Certain medical conditions make bacterial meningitis far more likely and more dangerous. People taking complement inhibitor medications are up to 2,000 times more likely to develop meningococcal disease compared to otherwise healthy individuals. These medications are used to treat blood and kidney disorders, among other conditions. If you take one, the CDC recommends meningococcal vaccination along with regular booster shots. Some doctors also prescribe ongoing preventive antibiotics for these patients, because vaccine protection alone appears to be incomplete in people on complement inhibitors.
Other high-risk groups include people without a functioning spleen, those with HIV, and anyone living in close quarters like college dormitories or military barracks. College freshmen living in residence halls face elevated risk because meningococcal bacteria spread through close, prolonged contact. Most U.S. colleges now require proof of MenACWY vaccination before move-in, and many health experts recommend that freshmen who were vaccinated more than three to five years before college consider revaccination.
How Meningitis Spreads
The bacteria that cause meningitis live in the nose and throat. They spread through respiratory droplets and direct contact with saliva. Kissing, sharing drinks, sharing vapes, and using someone else’s utensils or water bottles are common transmission routes. Importantly, the infection is usually spread by people who carry the bacteria without being sick themselves, which means you can’t tell who poses a risk just by looking at them.
To reduce your exposure:
- Don’t share drinks, utensils, vapes, or lip balm with others, especially in group living situations.
- Cover coughs and sneezes with your elbow rather than your hand.
- Wash your hands frequently, particularly before eating and after being in crowded spaces.
These habits won’t eliminate risk on their own, but they reduce the chance of picking up bacteria that your immune system then has to fight off.
What to Do After Exposure
If you’ve been in close contact with someone diagnosed with meningococcal meningitis, preventive antibiotics can stop the infection before it takes hold. Close contact generally means household members, romantic partners, or anyone who shared saliva or spent extended time face-to-face with the sick person. Casual contact at work or school typically doesn’t qualify.
The standard options are a single oral dose of ciprofloxacin, a single injection of ceftriaxone, or a short two-day course of rifampin. In areas where antibiotic-resistant strains have been identified, azithromycin may be used instead. Timing matters: prophylaxis is most effective when taken as soon as possible after the exposure is identified. Your local health department will typically coordinate this process and let you know if you need treatment.
Travel Precautions
Parts of sub-Saharan Africa, known as the “meningitis belt,” experience large seasonal outbreaks of meningococcal disease, particularly from December through June. If you’re traveling to or living in this region during those months, MenACWY vaccination is recommended before departure, even if you were vaccinated as a teenager and your booster window has passed.
Saudi Arabia requires documented proof of quadrivalent meningococcal vaccination for anyone aged one year and older making the Hajj or Umrah pilgrimage. For conjugate vaccines, the shot must have been given within the previous five years and at least 10 days before arrival. If you’re planning either pilgrimage, check your vaccination records well in advance, since some travelers need a fresh dose to meet the entry requirement.
Keeping Infants Protected Before Vaccination
Babies are among the most vulnerable to bacterial meningitis, and their vaccine series isn’t complete until around 15 months. During those early months, the doses they’ve received offer partial but growing protection. You can reduce an infant’s risk by keeping up with the recommended schedule (pneumococcal and Hib vaccines at 2, 4, and 6 months, with boosters around 12 to 15 months), limiting exposure to people with respiratory infections, and practicing good hand hygiene before handling the baby. Breastfeeding also passes along some of the mother’s immune protection during this vulnerable window.